USPTO serial 79355286
CEBIOTEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- WATKINS, JONATHAN RALPH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CEBIOTEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents for administering pharmaceuticals in the form of films which facilitate administration of pharmaceutical products; biopharmaceuticals for cancer treatment; drug delivery compounds that facilitate the delivery of pharmaceuticals; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating cancer; pharmaceutical preparations for oncological use; pharmaceutical preparations and substances for use in oncology; Veterinary products and substances for facilitating the delivery of pharmaceutical preparations; where all aforementioned goods exclude eye drops and pomades for ophthalmic or otorhinolaryngology use | ACTIVE | — |
| 007 | 3D printers; 3D bioprinters; three-dimensional (3D) living tissue manufacturing machines in the nature of 3D printers; machines for manufacturing medical and veterinary drugs, implants, and preparations | ACTIVE | — |
| 042 | Bacteriological research and consultancy; consultancy relating to research and development in the field of therapeutic drugs; development of pharmaceutical preparations and medicines; development of pharmaceutical products; design of diagnostic apparatus and equipment; biotechnological research; scientific research for medical purposes in oncology; scientific research relating to chemistry; research regarding pharmaceutical products; medical research; stem cell research; biochemical research and analysis; research and development of products; conducting clinical trials for pharmaceutical products for others; scientific laboratory services; information and data systems design in the field of medical and veterinary research and development; pharmaceutical and medical research services; biomedical research services; research and development services in bacteriology; provision of medical and scientific research information regarding results of clinical trials relating to pharmaceutical products; information, advisory and consultancy services in relation to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CEBIOTEX, S.L.
- Other trademarks owned by CEBIOTEX, S.L.
- Other trademarks owned by CEBIOTEX, S.L.
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 042
- Similar marks named CEBIOTEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 28, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 9, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 9, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 25, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 17, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 17, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 15, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 18, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 18, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 18, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 18, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 18, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 18, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 17, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 17, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 19, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 18, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 18, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 17, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |